Business Context and Reporting Period
Company: Keros Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 1, 2023
Reporting Period: Single event date (March 1, 2023)
This filing serves as a Regulation FD disclosure to announce an upcoming presentation by the Company's President and CEO, Jasbir Seehra, at Cowen's 43rd Annual Health Care Conference scheduled for March 8, 2023.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a corporate event and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document solely discloses the scheduling of a conference presentation.
Guidance, Outlook, and Management Commentary
- Management Commentary: The CEO, Jasbir Seehra, is scheduled to present at Cowen's 43rd Annual Health Care Conference on March 8, 2023, at 11:10 a.m. Eastern time.
- Guidance and Outlook: No specific financial guidance or operational outlook is provided in this filing text.
- Risks and Contingencies: No new risks or contingencies are disclosed in this specific report.
- Unusual Items: None reported.
Important Facts for Investor Verification
- Verify the date and time of the CEO's presentation at Cowen's 43rd Annual Health Care Conference (March 8, 2023, 11:10 a.m. ET).
- Review the attached press release (Exhibit 99.1) for any additional details regarding the presentation content.
- Note that the information in this 8-K is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.